Conformis Inc (CFMS) Fundamental Analysis & Valuation

NASDAQ:CFMS • US20717E2000

2.26 USD
0 (0%)
At close: Sep 1, 2023
2.26 USD
0 (0%)
After Hours: 9/1/2023, 8:00:15 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CFMS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

CFMS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. CFMS has a bad profitability rating. Also its financial health evaluation is rather negative. CFMS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. CFMS Profitability Analysis

1.1 Basic Checks

  • In the past year CFMS has reported negative net income.
  • In the past year CFMS has reported a negative cash flow from operations.
CFMS Yearly Net Income VS EBIT VS OCF VS FCFCFMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -10M -20M -30M -40M -50M

1.2 Ratios

  • The profitability ratios for CFMS are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CFMS Yearly ROA, ROE, ROICCFMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -50 -100 -150 -200

1.3 Margins

  • CFMS has a worse Gross Margin (33.21%) than 70.85% of its industry peers.
  • CFMS's Gross Margin has been stable in the last couple of years.
  • CFMS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.62%
GM growth 5Y0.29%
CFMS Yearly Profit, Operating, Gross MarginsCFMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CFMS Health Analysis

2.1 Basic Checks

  • CFMS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CFMS has been increased compared to 1 year ago.
  • CFMS has a worse debt/assets ratio than last year.
CFMS Yearly Shares OutstandingCFMS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
CFMS Yearly Total Debt VS Total AssetsCFMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 50M 100M

2.2 Solvency

  • CFMS has an Altman-Z score of -12.53. This is a bad value and indicates that CFMS is not financially healthy and even has some risk of bankruptcy.
  • CFMS's Altman-Z score of -12.53 is on the low side compared to the rest of the industry. CFMS is outperformed by 85.93% of its industry peers.
  • A Debt/Equity ratio of 0.64 indicates that CFMS is somewhat dependend on debt financing.
  • CFMS has a worse Debt to Equity ratio (0.64) than 70.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Altman-Z -12.53
ROIC/WACCN/A
WACC10.06%
CFMS Yearly LT Debt VS Equity VS FCFCFMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 50M -50M 100M

2.3 Liquidity

  • CFMS has a Current Ratio of 5.07. This indicates that CFMS is financially healthy and has no problem in meeting its short term obligations.
  • CFMS's Current ratio of 5.07 is fine compared to the rest of the industry. CFMS outperforms 64.32% of its industry peers.
  • CFMS has a Quick Ratio of 3.30. This indicates that CFMS is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 3.30, CFMS perfoms like the industry average, outperforming 58.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.07
Quick Ratio 3.3
CFMS Yearly Current Assets VS Current LiabilitesCFMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CFMS Growth Analysis

3.1 Past

  • CFMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.00%, which is quite impressive.
  • Looking at the last year, CFMS shows a decrease in Revenue. The Revenue has decreased by -5.72% in the last year.
  • Measured over the past years, CFMS shows a decrease in Revenue. The Revenue has been decreasing by -4.50% on average per year.
EPS 1Y (TTM)34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.89%
Revenue 1Y (TTM)-5.72%
Revenue growth 3Y-7.12%
Revenue growth 5Y-4.5%
Sales Q2Q%-14.85%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.18% on average over the next years. This is quite good.
  • CFMS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.56% yearly.
EPS Next Y24.27%
EPS Next 2Y15.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-8.57%
Revenue Next 2Y0.56%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CFMS Yearly Revenue VS EstimatesCFMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CFMS Yearly EPS VS EstimatesCFMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

More info and screens

Find the best growth stocksShow best growing peers

0

4. CFMS Valuation Analysis

4.1 Price/Earnings Ratio

  • CFMS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CFMS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CFMS Price Earnings VS Forward Price EarningsCFMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CFMS Per share dataCFMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CFMS's earnings are expected to grow with 15.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.18%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CFMS Dividend Analysis

5.1 Amount

  • No dividends for CFMS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CFMS Fundamentals: All Metrics, Ratios and Statistics

Conformis Inc

NASDAQ:CFMS (9/1/2023, 8:00:15 PM)

After market: 2.26 0 (0%)

2.26

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-02
Earnings (Next)10-31
Inst Owners0.01%
Inst Owner Change-99.93%
Ins Owners110.05%
Ins Owner Change0%
Market Cap17.80M
Revenue(TTM)57.06M
Net Income(TTM)-41.50M
Analysts80
Price Target2.32 (2.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.47%
Min EPS beat(2)-35.81%
Max EPS beat(2)6.86%
EPS beat(4)2
Avg EPS beat(4)9.06%
Min EPS beat(4)-35.81%
Max EPS beat(4)72.14%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.6%
Min Revenue beat(2)0.13%
Max Revenue beat(2)3.06%
Revenue beat(4)3
Avg Revenue beat(4)6.67%
Min Revenue beat(4)-1.47%
Max Revenue beat(4)24.96%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-95.46%
PT rev (3m)-95.46%
EPS NQ rev (1m)8.04%
EPS NQ rev (3m)8.04%
EPS NY rev (1m)0%
EPS NY rev (3m)0.25%
Revenue NQ rev (1m)2.16%
Revenue NQ rev (3m)2.16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.31
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB 0.56
EV/EBITDA N/A
EPS(TTM)-5.61
EYN/A
EPS(NY)-4.72
Fwd EYN/A
FCF(TTM)-5.92
FCFYN/A
OCF(TTM)-5.65
OCFYN/A
SpS7.24
BVpS4.07
TBVpS4.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.21%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.62%
GM growth 5Y0.29%
F-Score1
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 57.41%
Cap/Sales 3.76%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.07
Quick Ratio 3.3
Altman-Z -12.53
F-Score1
WACC10.06%
ROIC/WACCN/A
Cap/Depr(3y)58.59%
Cap/Depr(5y)68.68%
Cap/Sales(3y)3.37%
Cap/Sales(5y)3.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.89%
EPS Next Y24.27%
EPS Next 2Y15.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.72%
Revenue growth 3Y-7.12%
Revenue growth 5Y-4.5%
Sales Q2Q%-14.85%
Revenue Next Year-8.57%
Revenue Next 2Y0.56%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year46.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-299.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-342.58%
OCF growth 3YN/A
OCF growth 5YN/A

Conformis Inc / CFMS FAQ

Can you provide the ChartMill fundamental rating for Conformis Inc?

ChartMill assigns a fundamental rating of 2 / 10 to CFMS.


What is the valuation status of Conformis Inc (CFMS) stock?

ChartMill assigns a valuation rating of 0 / 10 to Conformis Inc (CFMS). This can be considered as Overvalued.


Can you provide the profitability details for Conformis Inc?

Conformis Inc (CFMS) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for CFMS stock?

The Earnings per Share (EPS) of Conformis Inc (CFMS) is expected to grow by 24.27% in the next year.